The pharmacology of potassium channels and their therapeutic potential

Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection.

Transplantation·1996

Decreased lumen size after balloon injury despite inhibition of neointimal thickening and antivasospastic treatment.

Cardiovascular research·1994

Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat.

Blood pressure·1993

The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.

Thrombosis and haemostasis·1993

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile.

Trends in pharmacological sciences·1993

Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.

Thrombosis and haemostasis·1993

B cells enter the synaptic conversation.

Trends in pharmacological sciences·2026

Lipophagy and lipid droplets in neurodegeneration.

Trends in pharmacological sciences·2026

Bias from within: intracellular allosterism and the ICL2 hub.

Trends in pharmacological sciences·2026

Closing AI drug-regulatory gaps through harmonized oversight.

Trends in pharmacological sciences·2026

Midnolin-directed protein degradation beyond ubiquitin.

Trends in pharmacological sciences·2026

Deubiquitinases in mitophagy: therapeutic control of mitochondrial quality.

Trends in pharmacological sciences·2026

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

The Annals of pharmacotherapy·2026

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Journal of opioid management·2026

Phospholipases D: An Update on Structure-Function Relationships.

Methods in molecular biology (Clifton, N.J.)·2026

Positive Allosteric GABAA Receptor Modulators Reduce Ethanol Consumption and Acute Functional Tolerance.

Alcohol (Fayetteville, N.Y.)·2026

Differential expression of µ-, δ-, and κ-opioid receptors in muscle afferents from male and female rats.

Molecular pain·2026

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

CNS drugs·2026

Related Experiment Videos

The pharmacology of potassium channels and their therapeutic potential

Related Concept Videos

Thrombin inhibition in an ex vivo model of porcine heart xenograft hyperacute rejection.

Decreased lumen size after balloon injury despite inhibition of neointimal thickening and antivasospastic treatment.

Spirapril and cilazapril inhibit neointimal lesion development but cause no detectable inhibition of lumen narrowing after carotid artery balloon catheter injury in the rat.

The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.

Synthetic low-molecular weight thrombin inhibitors: molecular design and pharmacological profile.

Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.

B cells enter the synaptic conversation.

Lipophagy and lipid droplets in neurodegeneration.

Bias from within: intracellular allosterism and the ICL2 hub.

Closing AI drug-regulatory gaps through harmonized oversight.

Midnolin-directed protein degradation beyond ubiquitin.

Deubiquitinases in mitophagy: therapeutic control of mitochondrial quality.

Lerodalcibep-liga as an Injectable Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)-Targeted Therapy for Patients With Hypercholesterolemia.

Examining physicians' behaviors regarding buprenorphine prescribing for opioid use disorder.

Phospholipases D: An Update on Structure-Function Relationships.

Positive Allosteric GABAA Receptor Modulators Reduce Ethanol Consumption and Acute Functional Tolerance.

Differential expression of µ-, δ-, and κ-opioid receptors in muscle afferents from male and female rats.

Approved Medications for Substance Use Disorders: An Umbrella Review of Systematic Reviews and Completed Phase 3 Randomized Controlled Trials.

Related Experiment Videos

The pharmacology of potassium channels and their therapeutic potential

Related Concept Videos

Related Articles